Oxalic Acid

Oxalic Acid

SCHEMBL9201711

C[C@H]1O[C@@](Cn2cncn2)(c2ccc(Cl)cc2)[C@H]1C.O=C(O)C(=O)O

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.40
THRB P10828 1/20 0.40
HTT P42858 3/20 0.38
MAPT P10636 1/20 0.38
POLB P06746 2/20 0.38
MC4R P32245 2/20 0.37
MC3R P41968 1/20 0.37
MC1R Q01726 1/20 0.37
HSP90AA1 P07900 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ALDH1A1 P00352 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 2/20 0.36
KMT2A Q03164 3/20 0.36
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL9201703 1.00 CYP3A4 (0.40) CYP3A4THRBHTTMAPTPOLB
SCHEMBL9735464 0.93 CYP3A4 (0.44) CYP3A4THRBHTTMAPTPOLB
SCHEMBL9199815 0.93 CYP3A4 (0.44) CYP3A4THRBHTTMAPTPOLB
SCHEMBL9199001 0.93 CYP3A4 (0.44) CYP3A4THRBHTTMAPTPOLB
SCHEMBL9843779 0.93 CYP3A4 (0.44) CYP3A4THRBHTTMAPTPOLB
SCHEMBL9741267 0.93 CYP3A4 (0.44) CYP3A4THRBHTTMAPTPOLB
SCHEMBL9736709 0.93 CYP3A4 (0.44) CYP3A4THRBHTTMAPTPOLB
SCHEMBL9198999 0.93 CYP3A4 (0.44) CYP3A4THRBHTTMAPTPOLB
Nitric Acid SCHEMBL9202704 0.89 KDM4E (0.47) CYP3A4THRBHTTMAPTPOLB
Nitric Acid SCHEMBL9202699 0.89 KDM4E (0.47) CYP3A4THRBHTTMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575425-B1 USE OF OXAZOLO- 2,3-a]ISOINDOLE AND IMIDAZO 2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO 2,3-a]ISOINDOLE DERIVATIVES BOEHRINGER MANNHEIM GMBH (DE) 1995-10-11 EP disclosed
EP-0431968-B1 Oxetane derivatives, their preparation and their use as anti-fungal or fungicidal agents SANKYO CO (JP) 1995-03-15 EP disclosed
EP-0575425-A1 USE OF OXAZOLO- 2,3-a]ISOINDOLE AND IMIDAZO 2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO 2,3-a]ISOINDOLE DERIVATIVES. BOEHRINGER MANNHEIM GMBH (DE) 1993-12-29 EP disclosed
WO-1992016207-A1 USE OF OXAZOLO-[2,3-a]ISOINDOLE AND IMIDAZO[2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO[2,3-a]ISOINDOLE DERIVATIVES BOEHRINGER MANNHEIM GMBH (DE) 1992-10-01 WO disclosed
US-5134152-A 1,2,4-Triazole compounds SANKYO COMPANY, LIMITED (JP) 1992-07-28 US disclosed
EP-0431968-A1 Oxetane derivatives, their preparation and their use as anti-fungal or fungicidal agents Sankyo Company Limited (JP) 1991-06-12 EP disclosed